Literature DB >> 11803442

Cocaine, reward, movement and monoamine transporters.

G R Uhl1, F S Hall, I Sora.   

Abstract

Recent evidence enriches our understanding of the molecular sites of action of cocaine reward and locomotor stimulation. Dopamine transporter blockade by cocaine appears a sufficient explanation for cocaine-induced locomotion. Variation in DAT appears to cause differences in locomotion without drug stimulation. However, previously-held views that DAT blockade was the sole site for cocaine reward have been replaced by a richer picture of multitransporter involvement with the rewarding and aversive actions of cocaine. These new insights, derived from studies of knockout mice with simultaneous deletions and/or blockade of multiple transporters, provide a novel model for the rewarding action of this heavily-abused substance and implicate multiple monoamine systems in cocaine's hedonic activities.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11803442     DOI: 10.1038/sj.mp.4000964

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  68 in total

Review 1.  Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6.

Authors:  Nian-Hang Chen; Maarten E A Reith; Michael W Quick
Journal:  Pflugers Arch       Date:  2003-04-29       Impact factor: 3.657

Review 2.  The role of the dopamine transporter in cocaine abuse.

Authors:  Sari Izenwasser
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

3.  Lmo4 in the nucleus accumbens regulates cocaine sensitivity.

Authors:  A W Lasek; D Kapfhamer; V Kharazia; J Gesch; F Giorgetti; U Heberlein
Journal:  Genes Brain Behav       Date:  2010-08-12       Impact factor: 3.449

Review 4.  Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction.

Authors:  Diwahar Narasimhan; James H Woods; Roger K Sunahara
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

5.  The κ-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial.

Authors:  David A Nielsen; Sara C Hamon; Thomas R Kosten
Journal:  Psychiatr Genet       Date:  2013-12       Impact factor: 2.458

6.  Chronic fluoxetine selectively upregulates dopamine D₁-like receptors in the hippocampus.

Authors:  Katsunori Kobayashi; Eisuke Haneda; Makoto Higuchi; Tetsuya Suhara; Hidenori Suzuki
Journal:  Neuropsychopharmacology       Date:  2012-01-25       Impact factor: 7.853

7.  Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine.

Authors:  Rae R Matsumoto; Su-Min Li; Jonathan L Katz; William E Fantegrossi; Andrew Coop
Journal:  Drug Alcohol Depend       Date:  2011-03-21       Impact factor: 4.492

8.  Structure and localisation of drug binding sites on neurotransmitter transporters.

Authors:  Aina W Ravna; Ingebrigt Sylte; Svein G Dahl
Journal:  J Mol Model       Date:  2009-02-24       Impact factor: 1.810

9.  NMDAR dependent intracellular responses associated with cocaine conditioned place preference behavior.

Authors:  Stephanie K Nygard; Anthony Klambatsen; Bailey Balouch; Vanya Quinones-Jenab; Shirzad Jenab
Journal:  Behav Brain Res       Date:  2016-09-21       Impact factor: 3.332

10.  Synthesis of 8-thiabicyclo[3.2.1]octanes and their binding affinity for the dopamine and serotonin transporters.

Authors:  Duy-Phong Pham-Huu; Jeffrey R Deschamps; Shanghao Liu; Bertha K Madras; Peter C Meltzer
Journal:  Bioorg Med Chem       Date:  2006-10-27       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.